Human cytomegalovirus IE1 and IE2 proteins are mutagenic and mediate “hit-and-run” oncogenic transformation in cooperation with the adenovirus E1A proteins

Bằng Shen, Yuqiao, Zhu, Hua, Shenk, Thomas
Được phát hành 1997

Analyses of Single-Amino-Acid Substitution Mutants of Adenovirus Type 5 E1B-55K Protein

Bằng Shen, Yuqiao, Kitzes, Galila, Nye, Julie A., Fattaey, Ali, Hermiston, Terry
Được phát hành 2001

Structural basis for the inhibition of poly(ADP-ribose) polymerases 1 and 2 by BMN 673, a potent inhibitor derived from dihydropyridophthalazinone

Bằng Aoyagi-Scharber, Mika, Gardberg, Anna S., Yip, Bryan K., Wang, Bing, Shen, Yuqiao, Fitzpatrick, Paul A.
Được phát hành 2014

Resistance to PARP inhibitors by SLFN11 inactivation can be overcome by ATR inhibition

Bằng Murai, Junko, Feng, Ying, Yu, Guoying K., Ru, Yuanbin, Tang, Sai-Wen, Shen, Yuqiao, Pommier, Yves
Xuất bản năm Oncotarget (2016)

BMN 673, a novel and highly potent PARP1/2 inhibitor for the treatment of human cancers with DNA repair deficiency

Bằng Shen, Yuqiao, Rehman, Farah L, Feng, Ying, Boshuizen, Julia, Bajrami, Ilirjana, Elliott, Richard, Wang, Bing, Lord, Christopher J., Post, Leonard E., Ashworth, Alan
Xuất bản năm Clin Cancer Res (2013)

Chinese Patent Medicines in the Treatment of Coronavirus Disease 2019 (COVID-19) in China

Bằng Zhuang, Wei, Fan, Zheng, Chu, Yanqi, Wang, Haizheng, Yang, Ying, Wu, Li, Sun, Nan, Sun, Ge, Shen, Yuqiao, Lin, Xiaolan, Guo, Guiming, Xi, Shengyan
Xuất bản năm Front Pharmacol (2020)

Developing Novel Oncolytic Adenoviruses through Bioselection

Bằng Yan, Wen, Kitzes, Galila, Dormishian, Farid, Hawkins, Lynda, Sampson-Johannes, Adam, Watanabe, Josh, Holt, Jenny, Lee, Vivian, Dubensky, Thomas, Fattaey, Ali, Hermiston, Terry, Balmain, Allan, Shen, Yuqiao
Được phát hành 2003

Proteomic markers of DNA repair and PI3K pathway activation predict response to the PARP inhibitor BMN 673 in small cell lung cancer

Bằng Cardnell, Robert, J, Feng, Ying, Diao, Lixia, Fan, You-Hong, Masrorpour, Fatemah, Wang, Jing, Shen, Yuqiao, Mills, Gordon, B, Minna, John, D, Heymach, John, V, Byers, Lauren, A
Được phát hành 2013

Activation of the PI3K/mTOR Pathway following PARP Inhibition in Small Cell Lung Cancer

Bằng Cardnell, Robert J., Feng, Ying, Mukherjee, Seema, Diao, Lixia, Tong, Pan, Stewart, C. Allison, Masrorpour, Fatemeh, Fan, YouHong, Nilsson, Monique, Shen, Yuqiao, Heymach, John V., Wang, Jing, Byers, Lauren A.
Xuất bản năm PLoS One (2016)

Restricted delivery of talazoparib across the blood-brain barrier limits the sensitizing effects of poly (ADP-ribose) polymerase inhibition on temozolomide therapy in glioblastoma

Bằng Kizilbash, Sani H., Gupta, Shiv K., Chang, Kenneth, Kawashima, Ryo, Parrish, Karen E., Carlson, Brett L., Bakken, Katrina K., Mladek, Ann C., Schroeder, Mark A., Decker, Paul A., Kitange, Gaspar J., Shen, Yuqiao, Feng, Ying, Protter, Andrew A., Elmquist, William F., Sarkaria, Jann N.
Xuất bản năm Mol Cancer Ther (2017)

Substrate reduction therapy for Krabbe disease and metachromatic leukodystrophy using a novel ceramide galactosyltransferase inhibitor

Bằng Babcock, Michael C., Mikulka, Christina R., Wang, Bing, Chandriani, Sanjay, Chandra, Sundeep, Xu, Yue, Webster, Katherine, Feng, Ying, Nelvagal, Hemanth R., Giaramita, Alex, Yip, Bryan K., Lo, Melanie, Jiang, Xuntian, Chao, Qi, Woloszynek, Josh C., Shen, Yuqiao, Bhagwat, Shripad, Sands, Mark S., Crawford, Brett E.
Xuất bản năm Sci Rep (2021)

Dynamic variations in epithelial-to-mesenchymal transition (EMT), ATM, and SLFN11 govern response to PARP inhibitors and cisplatin in small cell lung cancer

Bằng Stewart, C. Allison, Tong, Pan, Cardnell, Robert J., Sen, Triparna, Li, Lerong, Gay, Carl M., Masrorpour, Fatemah, Fan, You, Bara, Rasha O., Feng, Ying, Ru, Yuanbin, Fujimoto, Junya, Kundu, Samrat T., Post, Leonard E., Yu, Karen, Shen, Yuqiao, Glisson, Bonnie S., Wistuba, Ignacio, Heymach, John V., Gibbons, Don L., Wang, Jing, Byers, Lauren Averett
Xuất bản năm Oncotarget (2017)